Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WR | N.MMED.WS | N.MMED | N.MMED.WA

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by STOCKHITLISTon Apr 04, 2007 11:14am
574 Views
Post# 12546397

NEWS OUT - BLUEROCK RESOURCES - BRD

NEWS OUT - BLUEROCK RESOURCES - BRDBluerock Resources Starts Drilling at the Tramp Mine

4/4/2007

VANCOUVER, BRITISH COLUMBIA, Apr 4, 2007 (CCNMatthews via COMTEX News Network) --

Bluerock Resources Ltd. (TSX VENTURE:BRD) (the "Company") announces a drill rig has been mobilized to the Tramp Mine project, Montrose County, Colorado. Drilling is expected to start the week of April 9th, 2007.

This drill program will focus on three discrete targets that were defined by historic drilling(i). The three targets reported grades and intervals of 0.30% U3O8 over five feet (1.5m) and 0.82% U3O8 over 2.5 feet (0.75m) and 0.45% U3O8 over 1.5 feet (0.46m) at depths of 350 to 550 feet (90 to 170m), respectively. The historical intersections are located adjacent to existing underground mine workings which would facilitate rapid and efficient development.

The Tramp Mine produced Uranium and Vanadium ore from 1947 to 1984, with reported grades of 0.28% to 0.32% U3O8 and 1.5% to 1.7% V2O5. Production in the 1970's and 1980's was conducted with modern trackless mining methods on the lower rim (which is the target of the current exploration campaign). Portal access from the Canyon Rim affords the Company flexibility in developing the mine and reduces time and cost constraints that would apply to a shaft and tunnel operation.

With Mine, Exploration and Storm water permits in place, the Company is moving to define a 43-101 compliant resource, produce a scoping study and prepare the mine for production.

Bluerock President Michael Collins commented: "The quick start to drilling on the Tramp Mine Project demonstrates the Company's determination to actively advance its uranium projects toward production. Bluerock is committed to continue its strategy of acquiring and developing Uranium resources in the US south west."

Paul D. Gray, P.Geo. is the Qualified Person with respect to the Tramp Mine Project and has reviewed and approved this press release.

Bluerock Resources Ltd. is a uranium exploration company focused on discovering tomorrow's energy today through the acquisition and development of conventional uranium resources.

ON BEHALF OF THE BOARD OF DIRECTORS

Michael Collins, CEO, President and Director

(i) The historical work was conducted by previous mine operators, the reliability of this data is unknown but considered reasonable and confirmation work may produce results that differ substantially from the historic results.

Statements contained in this document that are not historical facts are forward-looking statements as that term is defined in the private securities litigation reform act of 1995. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from estimated results. Such risks and uncertainties are detailed in the Company's filing with the B.C. Securities Commission.

SOURCE: Bluerock Resources Ltd.

Bluerock Resources Ltd. Cary Martin Manager of Investor Relations (604) 687-2471 (604) 687-2472 (FAX) Email: cmartin@bluerockresources.com Website: www.bluerockresources.com

Copyright (C) 2007 CCNMatthews. All rights reserved.

Bullboard Posts